vs
Side-by-side financial comparison of APPIAN CORP (APPN) and Axsome Therapeutics, Inc. (AXSM). Click either name above to swap in a different company.
APPIAN CORP is the larger business by last-quarter revenue ($202.9M vs $196.0M, roughly 1.0× Axsome Therapeutics, Inc.). APPIAN CORP runs the higher net margin — -2.5% vs -14.6%, a 12.1% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 21.7%). APPIAN CORP produced more free cash flow last quarter ($270.0K vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 16.4%).
Appian Corporation is an American cloud computing and enterprise software company headquartered in McLean, Virginia, part of the Dulles Technology Corridor. The company sells a platform as a service (PaaS) for building enterprise software applications. It is focused on low-code development, process mining, business process management, and case management markets in North America, Europe, the Middle East and Southeast Asia.
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
APPN vs AXSM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $202.9M | $196.0M |
| Net Profit | $-5.1M | $-28.6M |
| Gross Margin | 64.8% | — |
| Operating Margin | -0.3% | -13.8% |
| Net Margin | -2.5% | -14.6% |
| Revenue YoY | 21.7% | 65.0% |
| Net Profit YoY | 62.6% | 61.9% |
| EPS (diluted) | $-0.06 | $-0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $202.9M | $196.0M | ||
| Q3 25 | $187.0M | $171.0M | ||
| Q2 25 | $170.6M | $150.0M | ||
| Q1 25 | $166.4M | $121.5M | ||
| Q4 24 | $166.7M | $118.8M | ||
| Q3 24 | $154.1M | $104.8M | ||
| Q2 24 | $146.4M | $87.2M | ||
| Q1 24 | $149.8M | $75.0M |
| Q4 25 | $-5.1M | $-28.6M | ||
| Q3 25 | $7.8M | $-47.2M | ||
| Q2 25 | $-312.0K | $-48.0M | ||
| Q1 25 | $-1.2M | $-59.4M | ||
| Q4 24 | $-13.6M | $-74.9M | ||
| Q3 24 | $-2.1M | $-64.6M | ||
| Q2 24 | $-43.6M | $-79.3M | ||
| Q1 24 | $-32.9M | $-68.4M |
| Q4 25 | 64.8% | — | ||
| Q3 25 | 75.8% | — | ||
| Q2 25 | 74.3% | — | ||
| Q1 25 | 76.6% | — | ||
| Q4 24 | 67.8% | — | ||
| Q3 24 | 75.9% | — | ||
| Q2 24 | 73.1% | — | ||
| Q1 24 | 74.6% | — |
| Q4 25 | -0.3% | -13.8% | ||
| Q3 25 | 7.0% | -27.0% | ||
| Q2 25 | -6.4% | -24.5% | ||
| Q1 25 | -0.5% | -46.9% | ||
| Q4 24 | 3.0% | -61.1% | ||
| Q3 24 | -4.6% | -59.8% | ||
| Q2 24 | -26.8% | -89.5% | ||
| Q1 24 | -13.0% | -89.7% |
| Q4 25 | -2.5% | -14.6% | ||
| Q3 25 | 4.2% | -27.6% | ||
| Q2 25 | -0.2% | -32.0% | ||
| Q1 25 | -0.7% | -48.9% | ||
| Q4 24 | -8.2% | -63.1% | ||
| Q3 24 | -1.4% | -61.7% | ||
| Q2 24 | -29.8% | -91.0% | ||
| Q1 24 | -22.0% | -91.1% |
| Q4 25 | $-0.06 | $-0.55 | ||
| Q3 25 | $0.10 | $-0.94 | ||
| Q2 25 | $0.00 | $-0.97 | ||
| Q1 25 | $-0.02 | $-1.22 | ||
| Q4 24 | $-0.18 | $-1.54 | ||
| Q3 24 | $-0.03 | $-1.34 | ||
| Q2 24 | $-0.60 | $-1.67 | ||
| Q1 24 | $-0.45 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $187.2M | $322.9M |
| Total DebtLower is stronger | $240.8M | — |
| Stockholders' EquityBook value | $-47.0M | $88.3M |
| Total Assets | $691.4M | $689.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $187.2M | $322.9M | ||
| Q3 25 | $191.6M | $325.3M | ||
| Q2 25 | $184.8M | $303.0M | ||
| Q1 25 | $199.7M | $300.9M | ||
| Q4 24 | $159.9M | $315.4M | ||
| Q3 24 | $99.2M | $327.3M | ||
| Q2 24 | $120.8M | $315.7M | ||
| Q1 24 | $170.1M | $331.4M |
| Q4 25 | $240.8M | — | ||
| Q3 25 | $245.7M | — | ||
| Q2 25 | $245.6M | — | ||
| Q1 25 | $248.0M | — | ||
| Q4 24 | $250.4M | — | ||
| Q3 24 | $252.8M | — | ||
| Q2 24 | $254.0M | — | ||
| Q1 24 | $255.1M | — |
| Q4 25 | $-47.0M | $88.3M | ||
| Q3 25 | $-48.5M | $73.7M | ||
| Q2 25 | $-53.7M | $73.1M | ||
| Q1 25 | $-31.7M | $53.2M | ||
| Q4 24 | $-32.6M | $57.0M | ||
| Q3 24 | $-49.8M | $92.9M | ||
| Q2 24 | $-45.7M | $102.9M | ||
| Q1 24 | $-9.7M | $144.0M |
| Q4 25 | $691.4M | $689.8M | ||
| Q3 25 | $611.7M | $669.3M | ||
| Q2 25 | $590.7M | $639.8M | ||
| Q1 25 | $592.9M | $596.7M | ||
| Q4 24 | $621.0M | $568.5M | ||
| Q3 24 | $549.9M | $561.5M | ||
| Q2 24 | $554.6M | $548.2M | ||
| Q1 24 | $595.4M | $545.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.1M | $-18.7M |
| Free Cash FlowOCF − Capex | $270.0K | $-18.7M |
| FCF MarginFCF / Revenue | 0.1% | -9.6% |
| Capex IntensityCapex / Revenue | 0.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $59.6M | $-93.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1M | $-18.7M | ||
| Q3 25 | $18.7M | $1.0M | ||
| Q2 25 | $-1.9M | $-32.4M | ||
| Q1 25 | $45.0M | $-43.4M | ||
| Q4 24 | $13.9M | $-26.2M | ||
| Q3 24 | $-8.2M | $-18.6M | ||
| Q2 24 | $-17.6M | $-30.1M | ||
| Q1 24 | $18.9M | $-53.5M |
| Q4 25 | $270.0K | $-18.7M | ||
| Q3 25 | $18.1M | $988.0K | ||
| Q2 25 | $-3.1M | $-32.4M | ||
| Q1 25 | $44.3M | $-43.7M | ||
| Q4 24 | $13.4M | $-26.2M | ||
| Q3 24 | $-8.6M | $-18.7M | ||
| Q2 24 | $-18.3M | $-30.2M | ||
| Q1 24 | $16.7M | $-53.6M |
| Q4 25 | 0.1% | -9.6% | ||
| Q3 25 | 9.7% | 0.6% | ||
| Q2 25 | -1.8% | -21.6% | ||
| Q1 25 | 26.6% | -36.0% | ||
| Q4 24 | 8.0% | -22.1% | ||
| Q3 24 | -5.6% | -17.9% | ||
| Q2 24 | -12.5% | -34.6% | ||
| Q1 24 | 11.1% | -71.4% |
| Q4 25 | 0.4% | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 0.2% | 0.1% | ||
| Q2 24 | 0.5% | 0.1% | ||
| Q1 24 | 1.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 2.39× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APPN
| Subscriptions Software And Support | $162.3M | 80% |
| Professional Services | $40.6M | 20% |
AXSM
Segment breakdown not available.
